Antineutrophil cytoplasmic antibodies (ANCA)

References

• Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989;6:12–13.
   Google Scholar
• Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: Possible arbovirus etiology? Br Med J 1982;285:606.
   PubMed Web of Science ®Google Scholar
• Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, Van Es LA, et al. Autoantibodies to neutrophils and mono-cytes: a new tool for diagnosis and a marker of disease activity in Wegener's granulomatosis. Lancet 1985;2:425–429.
   Google Scholar
• Falk RJ, Jennette IC. Anti-neutrophil cytoplasmic autoanti-bodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis . N Engl J Med 1988;318:1651–1657.
   PubMed Web of Science ®Google Scholar
• Goldschmeding R, Van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallemberg CGM. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Investig 1989; 84:1577–1587.
   PubMed Web of Science ®Google Scholar
• Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel diseases: prevalence and diagnostic role. Gut 1992;33:668–674.
   PubMed Web of Science ®Google Scholar
• Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G, Torgano G, et al. Antibodies to neutrophil cytoplasm in italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. Digestion 1994;55:34–39.
   PubMed Web of Science ®Google Scholar
• Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallemberg CGM. Prevalence and character-ization of anti-neutrophil cytoplasmic antibodies in auto-immune liver diseases. Hepatology 1993;17:411–417.
   PubMed Web of Science ®Google Scholar
• Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, Van der Voort EAM, Kleijburgvanderkeur C, et al. Anti-lactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466–2147.
   Google Scholar
• Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1–12.
   Google Scholar
• Peen E, Almer S, Bodemar G, Ryder BO, Sjolin C, Tejle K, et al. Antilactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn's disease. Gut 1993;34:56–62.
   PubMed Web of Science ®Google Scholar
• Halbwachs-Mecarelli LH, Nusbaum LH, Noel LH, Reumaux D, Erlinger S, Grunfeld JP, et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79–84.
   Google Scholar
• Kaneko K, Suzuki Y, Yamashiro Y, Yabuta S. Is p-ANCA in ulcerative colitis directed against 13-glucuronidase? Lancet 1993;341:320.
   PubMedGoogle Scholar
• Vecchi M, Sinico A, Bianchi MB, Radice A, Gionchetti P, Campieri M, et al. Recognition of Bactericidal/Permeability-Increasing Protein by Perinuclear Anti-Neutrophil Cyto-plasmic Antibody-Positive Sera from Ulcerative Colitis Patients: Prevalence and Clinical Significance. Scand J Gastroenterol 1998;33:1284–1288.
   PubMedGoogle Scholar
• Tadros M, Pozzi C, Radice A, Sinico RA, Tincani A. ANCA with specificity for lactoferrin in systemic lupus erithematosus (SLE). In: Gross WL, editor. ANCA-Associated Vasculitides: Immunological and Clinical Aspects. New York: Plenum Press; 1993. p 385–387.
   Google Scholar
• Merkel PA, Polisson RP, Chang YC, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Int Med 1997;126(11):866–873.
   Google Scholar
• O' Donoghue DJ, Nusbaum P, Noel LH, Halbwachs-Mecartelli L, Lesavre PM. Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schonlein purpura. Nephrol Dial Transplant 1992;7: 534–538.
   Google Scholar
• Saulsbury FT, Kirkpatrick PR, Bolton WK. IgA antineutrophil cytoplasmic antibody in Henoch-Schonlein purpura. Am J Nephrol 1991;2:295–300.
   Google Scholar
• Jayne DRW, Jones SJ, Severn A, Shaunak S, Murphy J, Lockwood CM. Severe pulmonary haemorrhage and systemic vasculitis in association with circulating antineutrophil cytoplasm antibodies of IgM class only. Clin Nephrol 1989;32:101–106.
   PubMed Web of Science ®Google Scholar
• Sinico RA, Tadros M, Radice A, Pozzi C, Quarenghi M, Comotti C, Gregorini G, Castiglione A, Arrigo G, D'Amico G. Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy. Clin Immunol Immunopathol 1994;73:19–26.
   Google Scholar
• Brouwer E, Tervaert JW, Horst G, Huitema MG, Van der Giessen M, Limburg PC, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991;83:379–386.
   Google Scholar
• Mulder AH, Stegeman CA, Kallenberg CG. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: A predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995;101: 227–232.
   Google Scholar
• Jayne DR, Westman AP, Lockwood CM. IgG subclass dis-tribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991;84:476–481.
   Google Scholar
• Nowack R, Grab I, Flores-Suarez LF, Schnulle P, Yard B, van der Woude F. ANCA titres, even of IgG subclasses, and soluble CD 14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2000;16: 1631–1637.
   Google Scholar
• Savige JA, Paspaliaris B, Silvestrini R, Davis DJ, Sturgess A, Neil J, et al. Immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other auto- and alloantibodies. J Clin Pathol 1998;51:568–575.
   PubMedGoogle Scholar
• Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk R, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999;111:507–513.
   PubMed Web of Science ®Google Scholar
• Wieslander J, Wiik A. ANCA antigens: Proteinase 3. In: Van Venrooy WJ, Maine RN, editors. Manual of Biological Markers of Disease. Vol. B7.1. Dordrecht: Kluwer Academy, 1994. p 1–9.
   Google Scholar
• Gabay JE, Scott RW, Campanelli D, Griffith J, Wilde C, Marra M, et al. Antibiotic proteins of human polymorpho-nuclear leukocytes. Prot Natl Acad Sci USA 1989; 86:5610–5614.
   PubMed Web of Science ®Google Scholar
• Kao RC, Wehner NG, Skubitz KIVI, Gray BH, Hoidal JR. Proteinase 3: A distinct human polymorphonuclear leukocyte proteinase that induces emphysema in hamsters. J Clin Investig 1988;82: 1963–1973
   Google Scholar
• Campbell EJ, Campbell MA, Owen CA. Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity and susceptibility to inhibition. J Immunol 2000;165: 3366–3374.
   Google Scholar
• Henshaw TJ, Malone CC, Gabay JE, Williams RC, Jr. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1994;37: 104–112.
   Google Scholar